2015
DOI: 10.3171/2014.12.focus14748
|View full text |Cite
|
Sign up to set email alerts
|

Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors

Abstract: OBJECT Chloroquine (CQ) is a quinoline-based drug widely used for the prevention and treatment of malaria. More recent studies have provided evidence that this drug may also harbor antitumor properties, whereby CQ possesses the ability to accumulate in lysosomes and blocks the cellular process of autophagy. Therefore, the authors of this study set out to investigate whether CQ analogs, in particular clinically established antimalaria drugs, would also be able to exer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
88
0
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 149 publications
(92 citation statements)
references
References 39 publications
2
88
0
2
Order By: Relevance
“…Indeed, antimalarial compounds, which share the ability to activate p53 and inhibit NF-ĸB, have been shown to be cytotoxic to glioma cells. 24 It is not surprising that TMZ was unable to increase survival in the A1207 model, since we found that A1207 expresses MGMT by western blot. MGMT expression is known to render the DNA O 6 alkylating agent TMZ ineffective because of its DNA repair function.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, antimalarial compounds, which share the ability to activate p53 and inhibit NF-ĸB, have been shown to be cytotoxic to glioma cells. 24 It is not surprising that TMZ was unable to increase survival in the A1207 model, since we found that A1207 expresses MGMT by western blot. MGMT expression is known to render the DNA O 6 alkylating agent TMZ ineffective because of its DNA repair function.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of TNF-α and IL-6. It also works as a novel class of autophagy inhibitor [81], which may interfere with viral infection and replication. Several studies have found that chloroquine interfered with the glycosylation of cellular receptors of SARS-CoV [80] and functioned at both entry and at post-entry stages of the COVID-19 infection in Vero E6 cells [82].…”
Section: Antiviral Treatmentsmentioning
confidence: 99%
“…However, the original cinchona alkaloids (Figure 1) did not inhibit autoph-agy at concentrations up to 30 mm (Table S1 in the Supporting Information). [19] Structure-activity relationships revealed that the unsubstituted b-iso-cupreidine, b-iso-quinidine,a nd b-iso-cinchonine (3, 4a,a nd 4b,r espectively) were not active at ac oncentration of 10 mm,t hus suggesting that substitution of the quinoline is required for activity.V arying the substitution at C2 produced several compounds that were active in the low micromolar range. Large 4-substituted phenyls (biphenyl or biphenyl ethers) were less well tolerated, however, a4 -fluorophenyl substituent significantly increased potencyt o 0.65 mm (5b).…”
Section: Furthermentioning
confidence: 99%
“…derivatives were accessed through C5 nitration to yield 14 (Scheme 1), [12] and subsequent reduction of the nitro group and acylationy ielded ureas or amides (15 a,b). Forf unctionalization at C6 (Scheme 1b), b-isocupreidine (3)w as converted into the triflate 16 to enable Suzuki couplings (17 a-c), Buchwald-Hartwig aminations (18 a,b), and Sonogashira couplings (19). Furthermore,etherification of 3 with chloroethyl ethyl ether and potassium tert-butoxide was successful and afforded compound 20.Inaddition, the lactone analogue 21 was synthesized from quinidine (2b;S cheme 1cand Scheme S1 in the Supporting Information).…”
Section: Furthermentioning
confidence: 99%